The healthcare management software producer received $74m in a series C round backed by China Pacific Insurance and will use the cash for product development.

Sofinnova Investments added $12m to a series B round backed by PureTech Health and Pivotal BioVenture Partners that has now closed at $80m.

The digital prescription platform's series A round included McKesson Ventures, Novartis, Philips, ResMed, Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin.

University of Michigan critical care monitoring technology spinout Fifth Eye has collected series A funding from investors including the university's Mints fund.

Pfizer spinoff Springworks has followed up its $103m series A round two years back by adding $125m in a round that also included GlaxoSmithKline.

The healthcare insurance and financing platform secured $74.3m in a Tencent-led series B round that will fund hiring and AI technology development.

Corporate venturing units Kamet Ventures and Dell Technologies Capital both contributed to a round that will fund the growth of Ibex Medical Analytics' team.

The corporate-backed genome editing technology developer Precision BioSciences, which was spun out of Duke University, floated in the middle of its range and is now valued at more than $780m.

The Baxter and Amgen-backed genome editing technology developer floated in the middle of its range and is now valued at more than $780m.

Founding investor Mercia Technologies joined fund manager Invesco for the synthetic biology contractor’s latest round, taking its total funding past the $25m mark.